Cargando…

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers

BACKGROUND: New oncology drugs are being developed in conjunction with companion diagnostics with approval restricting their use to certain biomarker-positive subgroups. We examined the impact of different predictive biomarker screening techniques and population enrichment criteria on the cost-effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atherly, A J, Camidge, D R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304427/ https://www.ncbi.nlm.nih.gov/pubmed/22374459 http://dx.doi.org/10.1038/bjc.2012.60

Ejemplares similares

Cost-Effectiveness of Total Colonoscopy in Screening of Colorectal Cancer in Japan
por: Sekiguchi, Masau, et al.
Publicado: (2012)

Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer
por: Cameron, D A, et al.
Publicado: (2008)

Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography
por: Toyoda, Y, et al.
Publicado: (2008)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Menon, Usha, et al.
Publicado: (2017)

Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening
por: Castleberry, A W, et al.
Publicado: (2009)

Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK
por: Camidge, D R, et al.
Publicado: (2007)

Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk
por: Ahern, C H, et al.
Publicado: (2014)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

Prescreening with FOBT Improves Yield and Is Cost-Effective in Colorectal Screening in the Elderly
por: Singhal, Shashideep, et al.
Publicado: (2014)

Clinical application of biological markers for treatments of resectable non-small-cell lung cancers
por: Huang, C, et al.
Publicado: (2005)

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
por: Calvert, N W, et al.
Publicado: (2003)

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
por: Griebsch, I, et al.
Publicado: (2006)

Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales
por: Chamberlain, C, et al.
Publicado: (2014)

Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system
por: Chow, I H-I, et al.
Publicado: (2010)

Telemedicine improves drug adherence and reduces OOP costs
Publicado: (2021)

Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness
por: de Bock, G H, et al.
Publicado: (2013)

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy
por: Sharp, L, et al.
Publicado: (2012)

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
por: Cappuzzo, F, et al.
Publicado: (2005)

The UK colorectal cancer screening pilot: results of the second round of screening in England
por: Weller, D, et al.
Publicado: (2007)

(18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Accuracy in the Staging of Non-Small Cell Lung Cancer: Review and Cost-Effectiveness
por: Gómez León, Nieves, et al.
Publicado: (2014)

Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme
por: Gill, M D, et al.
Publicado: (2012)

Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients
por: Teuffel, O, et al.
Publicado: (2011)

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
por: van den Bergh, K A M, et al.
Publicado: (2010)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

A micro costing of NHS cancer genetic services
por: Griffith, G L, et al.
Publicado: (2005)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer
por: Harding, V, et al.
Publicado: (2012)

Chlamydia trachomatis Infection in HIV-Infected Women: Need for Screening by a Sensitive and Specific Test
por: Bhattar, Sonali, et al.
Publicado: (2013)

Oral Fludrocortisone Test for Salt-Sensitive Screening in Hypertensive Patients: A Randomized Crossover Trial
por: Pio-Abreu, Andrea, et al.
Publicado: (2018)

Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
por: Shiroiwa, T, et al.
Publicado: (2009)

Unfavourable expression of pharmacologic markers in mucinous colorectal cancer
por: Glasgow, S C, et al.
Publicado: (2005)

Effect of Probiotic (VSL#3) and Omega-3 on Lipid Profile, Insulin Sensitivity, Inflammatory Markers, and Gut Colonization in Overweight Adults: A Randomized, Controlled Trial
por: Rajkumar, Hemalatha, et al.
Publicado: (2014)

Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review
por: Bryant, J, et al.
Publicado: (2007)

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival
por: Parker, C, et al.
Publicado: (2006)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer
por: Sutton, A J, et al.
Publicado: (2013)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patients
por: Jiang, L, et al.
Publicado: (2015)

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
por: Brydøy, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8ccvvjj3952b1455skt3ki6ug4